Navigation Links
Neuland Labs Reports Third Quarter Fiscal Year 2012 Financial Results
Date:2/10/2012

HYDERABAD, India, Feb. 10, 2012 /PRNewswire/ -- Neuland Laboratories Ltd., (NSE: NEULANDLAB; BOM: 524558) a pharmaceutical manufacturer providing active pharmaceutical ingredients (APIs), complex intermediates and contract research and manufacturing services to customers located in 85 countries, today announced financial results for the third quarter of fiscal year (FY) 2012, ended December 31, 2011.

Revenues for the third quarter of FY 2012 were $21.6 million (1.10 billion INR*) compared to revenues in the third quarter of FY 2011 of $19.0 million (968 million INR), an increase of about 13.7%.  The increase in revenues primarily reflects gains in sales of the company's products and services from its API, contract research and manufacturing, and peptides synthesis businesses.

Neuland reported EBITDA of $1.85 million (94.50 million INR) in the third quarter of FY 2012, compared to EBITDA of $2.19 million (111.85 million INR) in the comparable period in FY 2011, a decrease of about 15.5%.  The decrease in EBITDA in the current quarter primarily reflects higher materials and labor costs compared to the year-earlier period.

The company reported an after-tax loss in the third quarter of FY 2012 of ($0.67 million), (negative 34.00 million INR), compared to after-tax profits of $ 0.82 million (41.59 million INR) in the third quarter of FY 2011.  The loss reported in the third quarter of FY 2012 partly reflects non-cash, unrealized losses on foreign exchange rate hedges.

"In the third quarter of FY 2012 we reported good sales growth compared to the same period in FY 2011," noted Dr. D.R. Rao, Chairman and Managing Director of Neuland Labs.  "However, rising materials and labor costs, along with non-cash, unrealized expenses primarily associated with managing our foreign exchange needs generated a small loss for the quarter."

"We are pleased that Neuland increased its revenues in the third quarter of this year
'/>"/>

SOURCE Neuland Laboratories Ltd.
Copyright©2010 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Cepheid Reports Fourth Quarter and Full Year 2011 Results
2. Covance Reports Fourth Quarter Revenue of $532M, GAAP EPS of $0.35, Pro Forma EPS of $0.73, and Adjusted Net Orders of $759M
3. Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012
4. Idenix Reports Positive Interim Data for HCV Nucleotide Inhibitor, IDX184
5. Idenix Reports Advancement of HCV Development Pipeline
6. Hemodialysis Machine Industry 2012 Global & China Market Research Report - ReportsnReports
7. Neogen Reports Second Quarter Results
8. ReportsnReports - Aseptic Packaging to 2015
9. Biodel Reports Fourth Quarter Fiscal Year 2011 Financial Results
10. Hadasit Bio-Holdings Ltd. Reports Significant External Financing for Portfolio Companies
11. WaferGen Reports Third Quarter 2011 Financial Results and Announces New Commercialization Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2012)... physicist, vanadium oxide (VO2) may be the coolest material you,ve ... a window coating and an optical switch. And thanks to ... a new way to reversibly alter VO2,s electronic properties by ... , So what is VO2? It,s an oxidized form of ... reacts with vanadium to form VO2, the atoms form crystals ...
(Date:5/21/2012)... May 21, 2012   Cord Blood America, Inc ... CBAI ), the umbilical cord blood stem cell ... potential of stem cells to families nationwide and internationally, ... 2012 increased by 6.7%  to $1.55 million compared to ... announced a gross profit of $1.12 million in the ...
(Date:5/21/2012)... The Houston Technology Center (HTC), Texas, ... annual gala, "A Celebration of Entrepreneurs . ... made a significant impact on the region,s economy; ... The Houston Technology Center named Beth Williams, CEO ... the Founder and CEO of TechTrans International, Inc., ...
(Date:5/21/2012)... May 21, 2012  Neuralstem, Inc. (NYSE MKT: ... will present at the World Stem Cells & ... on Tuesday, May 22nd at 12:30 PM. Mr. ... will review Neuralstem,s cellular therapy trial in ALS, ... disorder (MDD), and provide an overview on plans ...
Breaking Biology Technology:Reversible doping: Hydrogen flips switch on vanadium oxide 2Reversible doping: Hydrogen flips switch on vanadium oxide 3Cord Blood America Announces First Quarter Financial Results 2Cord Blood America Announces First Quarter Financial Results 3Leading Technology Incubator Honors Extraordinary Entrepreneurs 2Leading Technology Incubator Honors Extraordinary Entrepreneurs 3Neuralstem CEO to Present at the World Stem Cells and Regenerative Medicine Congress in London 2
... Martek Biosciences,Corporation (Nasdaq: MATK ) today ... Court in Wilmington, Delaware, has ruled on various,post-trial ... Martek,s favor,against the defendants in the patent infringement ... and Nutrinova Nutrition Specialties &,Food Ingredients GmbH. The ...
... KOOL ), a leading supplier of innovative products ... of,adult stem cells for treatment of disease and injury, ... first quarter ended September,30, 2007, on Thursday, November 8, ... will host a conference call Thursday, November 8, 2007 ...
... - Canadian Biotechnology Company demonstrates the technical feasibility of ... in safflower - ... TSX symbol: SBS, ... company developing a portfolio of therapeutic,proteins for metabolic and cardiovascular diseases, ...
Other Biology Technology:Martek to Obtain Permanent Injunction Against Lonza in U.S. Patent Infringement Suit; Jury Verdict on Infringement of Two of Three Patents Upheld by Judge 2Martek to Obtain Permanent Injunction Against Lonza in U.S. Patent Infringement Suit; Jury Verdict on Infringement of Two of Three Patents Upheld by Judge 3ThermoGenesis Corp. to Announce First Quarter Fiscal 2008 Results on November 8, 2007 2ThermoGenesis Corp. to Announce First Quarter Fiscal 2008 Results on November 8, 2007 3SemBioSys announces 2007 third quarter results 2SemBioSys announces 2007 third quarter results 3SemBioSys announces 2007 third quarter results 4SemBioSys announces 2007 third quarter results 5SemBioSys announces 2007 third quarter results 6SemBioSys announces 2007 third quarter results 7SemBioSys announces 2007 third quarter results 8SemBioSys announces 2007 third quarter results 9SemBioSys announces 2007 third quarter results 10SemBioSys announces 2007 third quarter results 11SemBioSys announces 2007 third quarter results 12
(Date:5/21/2012)... team of scientists from the National University of Singapore,s ... discovered how a drug-led compound a compound that ... can deprive cancer cells of energy and stop them ... named BPTES. , This is the first time ... drug-lead compound suppresses tumour formation. , Building on ...
(Date:5/21/2012)... of Queensland has found a better way to ,spell ... to the May issue of the prestigious journal ... software implementation called Acacia. , Acacia analyses the output ... alphabet of As, Cs, Ts and Gs the ... genes of different living organisms. Acacia specifically applies to ...
(Date:5/21/2012)... Berlin, Germany, May 21, 2012 IMPACT World+, ... (LCIA) methodology was launched today in Berlin, Germany ... Europe 22nd Annual Meeting. The event featured the ... team of leading international LCIA experts and researchers ... goods and services generate significant detrimental impacts on ...
Breaking Biology News(10 mins):Novel discovery by NUS scientists paves the way for more effective treatment of cancers 2New approach to 'spell checking' gene sequences 2Launch of IMPACT World+ 2Video 3A Seventh Annual Avon Walk for Breast Cancer Los Angeles Raises More Than 244 6 Million 57088 1Video 3A Seventh Annual Avon Walk for Breast Cancer Los Angeles Raises More Than 244 6 Million 57088 2Video 3A Seventh Annual Avon Walk for Breast Cancer Los Angeles Raises More Than 244 6 Million 57088 3Video 3A Seventh Annual Avon Walk for Breast Cancer Los Angeles Raises More Than 244 6 Million 57088 4Video 3A Seventh Annual Avon Walk for Breast Cancer Los Angeles Raises More Than 244 6 Million 57088 5Haemacure Reports on Current Activities and Third Quarter 2009 Financial Results 57085 1Haemacure Reports on Current Activities and Third Quarter 2009 Financial Results 57085 2Haemacure Reports on Current Activities and Third Quarter 2009 Financial Results 57085 3Haemacure Reports on Current Activities and Third Quarter 2009 Financial Results 57085 4UCLA School of Dentistry to build new cancer research facility 57080 1UCLA School of Dentistry to build new cancer research facility 57080 2UCLA School of Dentistry to build new cancer research facility 57080 3
... bacteria have hijacked the human body,s immune response to play ... results of this takeover are mixed. The cells essentially welcome ... a while, meaning the human host becomes infected with the ... the infection remains latent and the infected person never has ...
... A plot of land on the campus of Auburn ... can produce similar cotton crops to those using other ... at the Agricultural and Mechanical College of Alabama (now ... that sustainable cotton production was possible on Alabama soils ...
... the Georgia Institute of Technology have developed a computer ... DNA sequences of fungi. , Fungi which range ... and human health, so understanding the recently sequenced fungal ... Gene prediction can also help to identify potential targets ...
Other Biology News:TB bacterium uses its sugar coat to sweeten its chances of living in lungs 2TB bacterium uses its sugar coat to sweeten its chances of living in lungs 3TB bacterium uses its sugar coat to sweeten its chances of living in lungs 4Experiment demonstrates 110 years of sustainable agriculture 2Researchers develop new self-training gene prediction program for fungi 2Researchers develop new self-training gene prediction program for fungi 3Researchers develop new self-training gene prediction program for fungi 4
... Thermo Labsystems' Wellwash AC is ... microplate washer available, and is ... for wash, waste and rinse ... and automatic rinsing and priming ...
... Rabbit polyclonal to MLF1 Interacting Protein/PBIP1 ... all tested applications). ... to amino acids 73-83 of Human ... Entrez Gene ID: 359815 ...
... save space and organize gloves, safety ... They are the perfect benchtop storage ... labs, processing and manufacturing. Clear static-dissipative ... particles they attract. Many other sizes ...
... These handy dispensers save space ... wipers, hats, and other garb. ... storage bins for small parts ... manufacturing. Clear acrylic. Many other ...
Biology Products: